Intercede Group (IGP) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
12 Oct, 2026Executive summary
H1 revenue was £8.21m, down 3.9% reported and 4.2% at constant currency, as delayed decisions weighed on performance; management expects H2 normalization and to meet FY26 expectations.
Strategy focuses on organic growth, gradual conversion from perpetual licences to subscriptions, geographic expansion and enterprise credential management for human and non-human identities.
Financial highlights
Revenue was £8.21m (H1 FY25: £8.54m); gross profit £7.82m (£8.24m) and operating profit £0.94m (£1.32m).
Profit before tax was £1.26m (£1.67m); net profit £1.24m (£1.67m); basic EPS 2.1p (2.8p).
Adjusted EBITDA was £1.3m (£1.8m); adjusted EPS was 2.2p basic and 2.1p diluted, versus 3.1p and 2.9p.
Operating expenses were £6.9m, or 84% of revenue versus 81%; £2.1m of product investment was expensed, with continued development and IT investment.
Outlook and guidance
Board expects to meet FY26 market expectations of £18.7m revenue and £4.6m adjusted pre-tax profit, supported by new orders, renewals and pipeline conversion.
Professional services are expected to recover in H2, with a normalized full-year run rate of £3.5m–£4m.
H2 priorities include product evolution, geographic expansion and targeted acquisitions; deferred revenue is expected to increase as multi-year subscription deals grow.
Strategic ambition is sustained double-digit organic growth, with ongoing investment in products, people and partners.
Latest events from Intercede Group
- Trading update due 8 October; H1 FY25 results expected 26 November.IGP
Trading update - H1 FY25 revenue expected up 22% YoY; period-end gross cash was £16.2m, with no debt.IGP
Trading update - Recurring revenue supported strong momentum, while gross cash rose to £18.7m with no debt.IGP
Trading update - Licence growth and c$3.2m of Q2 orders support maintained FY26 expectations.IGP
Trading update - ARR growth and H2 momentum underpin the reaffirmed £21m FY27 revenue target.IGP
Trading update - Record FY24 results and an expanded portfolio support the ambition to double FY23 revenue.IGP
H2 2024 - Revenue rose 22%, PBT 55%, with a larger pipeline supporting FY25 expectations.IGP
H1 2025 - Recurring revenue, product expansion and global demand underpin the double-digit growth target.IGP
H2 2025 - Delayed federal orders landed post-year-end; £21m FY27 guidance holds as recurring revenue grows.IGP
H2 2026